

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 7.54982011 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.46780462 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.46780462 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.08767633 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.90951570 |
| 6 | glutamate secretion (GO:0014047) | 6.56371595 |
| 7 | negative thymic T cell selection (GO:0045060) | 6.28940933 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.28008750 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.24230110 |
| 10 | negative T cell selection (GO:0043383) | 6.22779059 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 6.10206871 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.96786241 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.91146605 |
| 14 | negative regulation of cell killing (GO:0031342) | 5.91146605 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.88361559 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.35925739 |
| 17 | thymic T cell selection (GO:0045061) | 5.33270848 |
| 18 | neurotransmitter secretion (GO:0007269) | 5.31868436 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.29027375 |
| 20 | leukocyte aggregation (GO:0070486) | 5.26415285 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 5.08873002 |
| 22 | positive T cell selection (GO:0043368) | 5.05313130 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.03628380 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 5.00116635 |
| 25 | positive regulation of synapse maturation (GO:0090129) | 4.99577625 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.96909950 |
| 27 | response to interleukin-15 (GO:0070672) | 4.84439863 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 4.83529415 |
| 29 | locomotory exploration behavior (GO:0035641) | 4.80532923 |
| 30 | T cell migration (GO:0072678) | 4.79297522 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 4.77714124 |
| 32 | T cell selection (GO:0045058) | 4.69791906 |
| 33 | sodium ion export (GO:0071436) | 4.68972579 |
| 34 | layer formation in cerebral cortex (GO:0021819) | 4.68782710 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.68370194 |
| 36 | vocalization behavior (GO:0071625) | 4.65831558 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.63699220 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.56372852 |
| 39 | postsynaptic membrane organization (GO:0001941) | 4.49624427 |
| 40 | cerebellar granule cell differentiation (GO:0021707) | 4.49142596 |
| 41 | protein localization to synapse (GO:0035418) | 4.46995823 |
| 42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.43352517 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 4.37598503 |
| 44 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.35111661 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 4.32025086 |
| 46 | cell migration in hindbrain (GO:0021535) | 4.29504483 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.26511372 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.24158453 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.22867652 |
| 50 | interferon-gamma production (GO:0032609) | 4.22804277 |
| 51 | neuronal action potential propagation (GO:0019227) | 4.18546442 |
| 52 | exploration behavior (GO:0035640) | 4.17252860 |
| 53 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.16348029 |
| 54 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.14273101 |
| 55 | establishment of mitochondrion localization (GO:0051654) | 4.12929014 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 4.07105776 |
| 57 | neurotransmitter transport (GO:0006836) | 4.06801988 |
| 58 | T cell costimulation (GO:0031295) | 3.98752802 |
| 59 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.98358575 |
| 60 | synaptic vesicle endocytosis (GO:0048488) | 3.93777299 |
| 61 | T cell receptor signaling pathway (GO:0050852) | 3.92510740 |
| 62 | lymphocyte costimulation (GO:0031294) | 3.91343931 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.90885007 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.88156772 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.87159037 |
| 66 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.85228490 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.85112827 |
| 68 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.83896422 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82888914 |
| 70 | amino acid import (GO:0043090) | 3.81295032 |
| 71 | regulation of synapse maturation (GO:0090128) | 3.78862339 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.78037078 |
| 73 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75842637 |
| 74 | regulation of B cell differentiation (GO:0045577) | 3.75594075 |
| 75 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.72560106 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 3.72437458 |
| 77 | neuronal ion channel clustering (GO:0045161) | 3.71740833 |
| 78 | regulation of vesicle fusion (GO:0031338) | 3.71407708 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 3.71157151 |
| 80 | neuron-neuron synaptic transmission (GO:0007270) | 3.69053877 |
| 81 | auditory behavior (GO:0031223) | 3.66592135 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.66251435 |
| 83 | tolerance induction (GO:0002507) | 3.65203996 |
| 84 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.64398820 |
| 85 | negative regulation of phagocytosis (GO:0050765) | 3.62084999 |
| 86 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.56571999 |
| 87 | neuron recognition (GO:0008038) | 3.52681833 |
| 88 | positive regulation of lamellipodium assembly (GO:0010592) | 3.52603870 |
| 89 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.52362007 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.49233044 |
| 91 | glutamate receptor signaling pathway (GO:0007215) | 3.49056783 |
| 92 | positive regulation of isotype switching (GO:0045830) | 3.48319680 |
| 93 | positive regulation of membrane potential (GO:0045838) | 3.48122957 |
| 94 | regulation of neurotransmitter secretion (GO:0046928) | 3.46805658 |
| 95 | neuromuscular process controlling balance (GO:0050885) | 3.46289107 |
| 96 | axonal fasciculation (GO:0007413) | 3.45498727 |
| 97 | potassium ion homeostasis (GO:0055075) | 3.44506499 |
| 98 | positive regulation of dendritic spine development (GO:0060999) | 3.44232237 |
| 99 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.41442825 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 3.40491811 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.38074228 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37162925 |
| 103 | regulation of synaptic plasticity (GO:0048167) | 3.36891867 |
| 104 | regulation of response to interferon-gamma (GO:0060330) | 3.36605621 |
| 105 | L-amino acid import (GO:0043092) | 3.35689251 |
| 106 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34631397 |
| 107 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.34083692 |
| 108 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.33573523 |
| 109 | dendritic spine organization (GO:0097061) | 3.32621539 |
| 110 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.32077929 |
| 111 | cerebellar Purkinje cell layer development (GO:0021680) | 3.30771710 |
| 112 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.26922654 |
| 113 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.26893557 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 3.26653064 |
| 115 | cell communication by electrical coupling (GO:0010644) | 3.25808019 |
| 116 | mitochondrion transport along microtubule (GO:0047497) | 3.25590925 |
| 117 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.25590925 |
| 118 | leukocyte cell-cell adhesion (GO:0007159) | 3.24939091 |
| 119 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.23643616 |
| 120 | positive regulation of humoral immune response (GO:0002922) | 3.23118659 |
| 121 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.22880665 |
| 122 | mast cell activation (GO:0045576) | 3.22840936 |
| 123 | positive regulation of interleukin-2 production (GO:0032743) | 3.22723908 |
| 124 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.22646869 |
| 125 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.22646869 |
| 126 | long-term memory (GO:0007616) | 3.22125908 |
| 127 | nucleobase catabolic process (GO:0046113) | 3.20561793 |
| 128 | positive regulation of tolerance induction (GO:0002645) | 3.20199372 |
| 129 | neuromuscular synaptic transmission (GO:0007274) | 3.19554690 |
| 130 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.18497674 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 3.14809779 |
| 132 | defense response to fungus (GO:0050832) | 3.14048665 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 3.13976105 |
| 134 | activated T cell proliferation (GO:0050798) | 3.13626362 |
| 135 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13200851 |
| 136 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12428511 |
| 137 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11153954 |
| 138 | actin nucleation (GO:0045010) | 3.11100101 |
| 139 | positive regulation of B cell mediated immunity (GO:0002714) | 3.09899360 |
| 140 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.09899360 |
| 141 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06754668 |
| 142 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.06683021 |
| 143 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05978271 |
| 144 | membrane depolarization during action potential (GO:0086010) | 3.05353697 |
| 145 | T cell homeostasis (GO:0043029) | 3.05235985 |
| 146 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.03139433 |
| 147 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.02758809 |
| 148 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01867218 |
| 149 | response to auditory stimulus (GO:0010996) | 3.00326164 |
| 150 | synaptic vesicle transport (GO:0048489) | 2.99248853 |
| 151 | establishment of synaptic vesicle localization (GO:0097480) | 2.99248853 |
| 152 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.98325865 |
| 153 | myeloid dendritic cell differentiation (GO:0043011) | 2.97631374 |
| 154 | positive regulation of lamellipodium organization (GO:1902745) | 2.97054267 |
| 155 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.96710176 |
| 156 | regulation of isotype switching (GO:0045191) | 2.96026528 |
| 157 | membrane depolarization (GO:0051899) | 2.95803831 |
| 158 | lymphocyte migration (GO:0072676) | 2.95271173 |
| 159 | protein retention in ER lumen (GO:0006621) | 2.94443181 |
| 160 | proline transport (GO:0015824) | 2.93881085 |
| 161 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.93765504 |
| 162 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.93765504 |
| 163 | positive regulation of neurotransmitter transport (GO:0051590) | 2.93252398 |
| 164 | negative regulation of microtubule polymerization (GO:0031115) | 2.93223885 |
| 165 | natural killer cell differentiation (GO:0001779) | 2.92958294 |
| 166 | regulation of B cell mediated immunity (GO:0002712) | 2.92631439 |
| 167 | presynaptic membrane assembly (GO:0097105) | 2.92540596 |
| 168 | regulation of dendritic spine development (GO:0060998) | 2.92289396 |
| 169 | transmission of nerve impulse (GO:0019226) | 2.92198680 |
| 170 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.91884036 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91871362 |
| 172 | natural killer cell activation (GO:0030101) | 2.90695273 |
| 173 | dendrite morphogenesis (GO:0048813) | 2.90310862 |
| 174 | synapse assembly (GO:0007416) | 2.89643194 |
| 175 | response to type I interferon (GO:0034340) | 2.89300758 |
| 176 | neuromuscular process (GO:0050905) | 2.89156228 |
| 177 | regulation of tolerance induction (GO:0002643) | 2.88910107 |
| 178 | cell differentiation in hindbrain (GO:0021533) | 2.88684569 |
| 179 | cellular sodium ion homeostasis (GO:0006883) | 2.88516979 |
| 180 | presynaptic membrane organization (GO:0097090) | 2.88045240 |
| 181 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.87150743 |
| 182 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.86755798 |
| 183 | positive regulation of immunoglobulin production (GO:0002639) | 2.85717933 |
| 184 | cellular response to zinc ion (GO:0071294) | 2.85562439 |
| 185 | cellular extravasation (GO:0045123) | 2.85188850 |
| 186 | type I interferon signaling pathway (GO:0060337) | 2.84289956 |
| 187 | cellular response to type I interferon (GO:0071357) | 2.84289956 |
| 188 | response to fungus (GO:0009620) | 2.82160585 |
| 189 | positive regulation of DNA recombination (GO:0045911) | 2.80741773 |
| 190 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79866646 |
| 191 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.79491433 |
| 192 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.79491433 |
| 193 | mast cell activation involved in immune response (GO:0002279) | 2.75490618 |
| 194 | mast cell degranulation (GO:0043303) | 2.75490618 |
| 195 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.75416163 |
| 196 | lymphocyte homeostasis (GO:0002260) | 2.73052678 |
| 197 | regulation of regulatory T cell differentiation (GO:0045589) | 2.72954403 |
| 198 | regulation of hypersensitivity (GO:0002883) | 2.72036707 |
| 199 | negative regulation of interleukin-12 production (GO:0032695) | 2.67860669 |
| 200 | mature B cell differentiation (GO:0002335) | 2.67660862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.52920936 |
| 2 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 5.05166131 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.69575825 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.52244492 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12249225 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.72525487 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.24980236 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.24323574 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.23692249 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.21857977 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19044701 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14622655 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.02460078 |
| 14 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 3.00351788 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99937190 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87916150 |
| 17 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87492952 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.79366532 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.79267070 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.78612273 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76493575 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74173883 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.70153892 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.69455851 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68847097 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.66643719 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63887827 |
| 28 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62708264 |
| 29 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62708264 |
| 30 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61904722 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56037605 |
| 32 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55461397 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53813123 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.53757958 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52994561 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.45839609 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45442853 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 2.44949696 |
| 39 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44507186 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.39748021 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.38709396 |
| 42 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37709049 |
| 43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36317320 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35237939 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.34604256 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30498123 |
| 47 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26949252 |
| 48 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25853229 |
| 49 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23131305 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21359485 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17843295 |
| 52 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17815352 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.17581980 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15627544 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14122236 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.09645132 |
| 57 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08044490 |
| 58 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.07969561 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07933265 |
| 60 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07416556 |
| 61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.03077071 |
| 62 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02806194 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02471895 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94159510 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92716735 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.92312564 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92068105 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.91748184 |
| 69 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.90792255 |
| 70 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88726962 |
| 71 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86293021 |
| 72 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.84667461 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.84246686 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82193334 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80645049 |
| 76 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.78373080 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72334793 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71936672 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70020343 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65371577 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.64545403 |
| 82 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63841419 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.63811513 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63403226 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.60950722 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.60897536 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.59154639 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.58801770 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55209784 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54822355 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54245624 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51508504 |
| 93 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.51221205 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50680567 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50372390 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49079416 |
| 97 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.48673595 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46642436 |
| 99 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.43344897 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35613326 |
| 101 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35380910 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34859429 |
| 103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34747973 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32219907 |
| 105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31913918 |
| 106 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28679173 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28378357 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27574136 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27258749 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27099955 |
| 111 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25183149 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25142272 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25074287 |
| 114 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24842423 |
| 115 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22977466 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20030252 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19611049 |
| 118 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18907648 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18857410 |
| 120 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17963458 |
| 121 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.17432229 |
| 122 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17025964 |
| 123 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16650580 |
| 124 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.15889472 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15860280 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13662315 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13466024 |
| 128 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12877355 |
| 129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11619791 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10841568 |
| 131 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10829876 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10457550 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08286474 |
| 134 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08136232 |
| 135 | AR_19668381_ChIP-Seq_PC3_Human | 1.07704963 |
| 136 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07615552 |
| 137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06505584 |
| 138 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06482141 |
| 139 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05259690 |
| 140 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05130144 |
| 141 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04775597 |
| 142 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04487911 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04062656 |
| 144 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03443005 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02665634 |
| 146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02512098 |
| 147 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02445157 |
| 148 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.01917347 |
| 149 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.97433144 |
| 150 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.97073322 |
| 151 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96353070 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96328324 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95417589 |
| 154 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.95187330 |
| 155 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94535608 |
| 156 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94353844 |
| 157 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93760226 |
| 158 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93398825 |
| 159 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93003886 |
| 160 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92833955 |
| 161 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92157844 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92005074 |
| 163 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91950507 |
| 164 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91375511 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91360774 |
| 166 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90705194 |
| 167 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90564805 |
| 168 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90200149 |
| 169 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90188839 |
| 170 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.89480572 |
| 171 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88320825 |
| 172 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87778331 |
| 173 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87461031 |
| 174 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87179381 |
| 175 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.86803346 |
| 176 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86475420 |
| 177 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85589700 |
| 178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85060104 |
| 179 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84856513 |
| 180 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.84639509 |
| 181 | P68_20966046_ChIP-Seq_HELA_Human | 0.84429873 |
| 182 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83335518 |
| 183 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83330937 |
| 184 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.83026432 |
| 185 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82903762 |
| 186 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82024906 |
| 187 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81946691 |
| 188 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.80182527 |
| 189 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.79776896 |
| 190 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78235261 |
| 191 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.77389740 |
| 192 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.75885833 |
| 193 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74913090 |
| 194 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.74815246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.25817007 |
| 2 | MP0003880_abnormal_central_pattern | 4.37893897 |
| 3 | MP0004270_analgesia | 4.26858394 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.94163825 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.79553439 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.73023695 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.59141087 |
| 8 | MP0000685_abnormal_immune_system | 3.30761228 |
| 9 | MP0005671_abnormal_response_to | 3.27709316 |
| 10 | * MP0002064_seizures | 3.14094235 |
| 11 | MP0002063_abnormal_learning/memory/cond | 3.08404888 |
| 12 | MP0003303_peritoneal_inflammation | 3.03416824 |
| 13 | MP0003436_decreased_susceptibility_to | 2.95749338 |
| 14 | MP0001800_abnormal_humoral_immune | 2.93353608 |
| 15 | MP0009745_abnormal_behavioral_response | 2.91771001 |
| 16 | MP0009046_muscle_twitch | 2.91045914 |
| 17 | MP0005387_immune_system_phenotype | 2.88216644 |
| 18 | MP0001790_abnormal_immune_system | 2.88216644 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.74466006 |
| 20 | MP0009785_altered_susceptibility_to | 2.73043145 |
| 21 | MP0002272_abnormal_nervous_system | 2.72517681 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.72247369 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.62793314 |
| 24 | MP0001873_stomach_inflammation | 2.60478658 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.54582024 |
| 26 | MP0002723_abnormal_immune_serum | 2.53313454 |
| 27 | MP0005025_abnormal_response_to | 2.51103284 |
| 28 | MP0001819_abnormal_immune_cell | 2.51001547 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.49911357 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.48363740 |
| 31 | MP0001968_abnormal_touch/_nociception | 2.46071841 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.44731176 |
| 33 | MP0002398_abnormal_bone_marrow | 2.36725848 |
| 34 | MP0001486_abnormal_startle_reflex | 2.27434885 |
| 35 | MP0008569_lethality_at_weaning | 2.19059895 |
| 36 | MP0005360_urolithiasis | 2.18687345 |
| 37 | MP0002396_abnormal_hematopoietic_system | 2.18362636 |
| 38 | MP0002405_respiratory_system_inflammati | 2.17482933 |
| 39 | MP0005464_abnormal_platelet_physiology | 2.17249776 |
| 40 | MP0002419_abnormal_innate_immunity | 2.17026022 |
| 41 | MP0002735_abnormal_chemical_nociception | 2.15788964 |
| 42 | * MP0000716_abnormal_immune_system | 2.14768595 |
| 43 | MP0010155_abnormal_intestine_physiology | 2.12801912 |
| 44 | MP0000778_abnormal_nervous_system | 2.12343087 |
| 45 | MP0003866_abnormal_defecation | 2.09960141 |
| 46 | MP0002006_tumorigenesis | 2.09279271 |
| 47 | MP0006082_CNS_inflammation | 2.00475969 |
| 48 | MP0004510_myositis | 1.99500763 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.99042908 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.96786470 |
| 51 | MP0002722_abnormal_immune_system | 1.93041479 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.91531573 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.91287793 |
| 54 | MP0003122_maternal_imprinting | 1.90922447 |
| 55 | MP0004947_skin_inflammation | 1.90033108 |
| 56 | MP0002736_abnormal_nociception_after | 1.89109459 |
| 57 | MP0003724_increased_susceptibility_to | 1.88946820 |
| 58 | MP0003879_abnormal_hair_cell | 1.83836643 |
| 59 | MP0009840_abnormal_foam_cell | 1.82936217 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.81452482 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.79322005 |
| 62 | MP0001970_abnormal_pain_threshold | 1.77798452 |
| 63 | * MP0002429_abnormal_blood_cell | 1.77367116 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.75052016 |
| 65 | MP0000955_abnormal_spinal_cord | 1.71098620 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.70769484 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.69070119 |
| 68 | MP0002184_abnormal_innervation | 1.68730517 |
| 69 | MP0001188_hyperpigmentation | 1.68388669 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.62645814 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.62096539 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.62077024 |
| 73 | MP0001853_heart_inflammation | 1.62052791 |
| 74 | * MP0002067_abnormal_sensory_capabilities | 1.61549228 |
| 75 | * MP0002882_abnormal_neuron_morphology | 1.60521939 |
| 76 | * MP0002066_abnormal_motor_capabilities/c | 1.52754256 |
| 77 | MP0001529_abnormal_vocalization | 1.52237791 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.49493814 |
| 79 | MP0005310_abnormal_salivary_gland | 1.49234174 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 1.47766164 |
| 81 | MP0005623_abnormal_meninges_morphology | 1.43872021 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 1.43791961 |
| 83 | MP0008469_abnormal_protein_level | 1.42585022 |
| 84 | MP0004924_abnormal_behavior | 1.41290478 |
| 85 | MP0005386_behavior/neurological_phenoty | 1.41290478 |
| 86 | MP0003787_abnormal_imprinting | 1.41174436 |
| 87 | MP0005365_abnormal_bile_salt | 1.36866850 |
| 88 | MP0001984_abnormal_olfaction | 1.35741689 |
| 89 | MP0000604_amyloidosis | 1.32330444 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.29435579 |
| 91 | * MP0002152_abnormal_brain_morphology | 1.29162671 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 1.27717959 |
| 93 | MP0002933_joint_inflammation | 1.27669257 |
| 94 | MP0009780_abnormal_chondrocyte_physiolo | 1.25291287 |
| 95 | MP0003172_abnormal_lysosome_physiology | 1.24824964 |
| 96 | MP0003123_paternal_imprinting | 1.23669591 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 1.22673566 |
| 98 | MP0000858_altered_metastatic_potential | 1.22397708 |
| 99 | MP0001177_atelectasis | 1.21784363 |
| 100 | MP0005646_abnormal_pituitary_gland | 1.21608252 |
| 101 | MP0004885_abnormal_endolymph | 1.20952793 |
| 102 | MP0000490_abnormal_crypts_of | 1.20632684 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 1.19966590 |
| 104 | MP0001905_abnormal_dopamine_level | 1.17793175 |
| 105 | MP0001666_abnormal_nutrient_absorption | 1.17238199 |
| 106 | MP0000609_abnormal_liver_physiology | 1.16840077 |
| 107 | MP0004858_abnormal_nervous_system | 1.15957319 |
| 108 | MP0003183_abnormal_peptide_metabolism | 1.15431626 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 1.12480247 |
| 110 | MP0001545_abnormal_hematopoietic_system | 1.12480247 |
| 111 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11009069 |
| 112 | MP0001663_abnormal_digestive_system | 1.10674782 |
| 113 | MP0000920_abnormal_myelination | 1.09742603 |
| 114 | MP0004742_abnormal_vestibular_system | 1.08402065 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 1.08382025 |
| 116 | MP0010329_abnormal_lipoprotein_level | 1.07873418 |
| 117 | MP0003634_abnormal_glial_cell | 1.07743840 |
| 118 | MP0010234_abnormal_vibrissa_follicle | 1.07598486 |
| 119 | MP0004142_abnormal_muscle_tone | 1.04702511 |
| 120 | MP0000751_myopathy | 1.04532140 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 1.04405339 |
| 122 | * MP0003633_abnormal_nervous_system | 1.02332135 |
| 123 | MP0008961_abnormal_basal_metabolism | 1.00962295 |
| 124 | MP0005058_abnormal_lysosome_morphology | 1.00504657 |
| 125 | MP0005083_abnormal_biliary_tract | 1.00425350 |
| 126 | * MP0003631_nervous_system_phenotype | 1.00403276 |
| 127 | MP0009764_decreased_sensitivity_to | 0.97799138 |
| 128 | MP0003252_abnormal_bile_duct | 0.96677160 |
| 129 | MP0003121_genomic_imprinting | 0.96429854 |
| 130 | MP0001851_eye_inflammation | 0.96159085 |
| 131 | MP0002229_neurodegeneration | 0.94668781 |
| 132 | MP0003861_abnormal_nervous_system | 0.94224030 |
| 133 | MP0002822_catalepsy | 0.94129844 |
| 134 | MP0005174_abnormal_tail_pigmentation | 0.91961980 |
| 135 | MP0003690_abnormal_glial_cell | 0.91046809 |
| 136 | MP0009763_increased_sensitivity_to | 0.90715932 |
| 137 | MP0002019_abnormal_tumor_incidence | 0.90052491 |
| 138 | MP0003448_altered_tumor_morphology | 0.88678095 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.87468574 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.85603406 |
| 141 | MP0002752_abnormal_somatic_nervous | 0.84145583 |
| 142 | MP0003632_abnormal_nervous_system | 0.83883947 |
| 143 | MP0005166_decreased_susceptibility_to | 0.83840235 |
| 144 | MP0000462_abnormal_digestive_system | 0.83286772 |
| 145 | MP0002249_abnormal_larynx_morphology | 0.82985342 |
| 146 | MP0005394_taste/olfaction_phenotype | 0.82242971 |
| 147 | MP0005499_abnormal_olfactory_system | 0.82242971 |
| 148 | MP0003329_amyloid_beta_deposits | 0.81909894 |
| 149 | MP0002069_abnormal_eating/drinking_beha | 0.81155225 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80145733 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.77881045 |
| 152 | MP0000579_abnormal_nail_morphology | 0.77422497 |
| 153 | MP0000631_abnormal_neuroendocrine_gland | 0.76576404 |
| 154 | * MP0001943_abnormal_respiration | 0.76481370 |
| 155 | MP0000534_abnormal_ureter_morphology | 0.75452992 |
| 156 | MP0003075_altered_response_to | 0.74798022 |
| 157 | MP0005075_abnormal_melanosome_morpholog | 0.73179654 |
| 158 | MP0002254_reproductive_system_inflammat | 0.73173476 |
| 159 | MP0003656_abnormal_erythrocyte_physiolo | 0.73090421 |
| 160 | MP0005076_abnormal_cell_differentiation | 0.71550238 |
| 161 | MP0010769_abnormal_survival | 0.70863478 |
| 162 | MP0002132_abnormal_respiratory_system | 0.70831722 |
| 163 | MP0001346_abnormal_lacrimal_gland | 0.70178433 |
| 164 | MP0001963_abnormal_hearing_physiology | 0.69833788 |
| 165 | MP0002081_perinatal_lethality | 0.69744832 |
| 166 | MP0005187_abnormal_penis_morphology | 0.69256210 |
| 167 | MP0002082_postnatal_lethality | 0.69173088 |
| 168 | MP0010770_preweaning_lethality | 0.69173088 |
| 169 | MP0000598_abnormal_liver_morphology | 0.67976276 |
| 170 | MP0010768_mortality/aging | 0.67757103 |
| 171 | MP0008873_increased_physiological_sensi | 0.67008300 |
| 172 | MP0005409_darkened_coat_color | 0.66684002 |
| 173 | MP0005023_abnormal_wound_healing | 0.66641721 |
| 174 | MP0009278_abnormal_bone_marrow | 0.66342847 |
| 175 | MP0001348_abnormal_lacrimal_gland | 0.65836454 |
| 176 | MP0003385_abnormal_body_wall | 0.65681946 |
| 177 | MP0008874_decreased_physiological_sensi | 0.65003626 |
| 178 | MP0004233_abnormal_muscle_weight | 0.63987117 |
| 179 | MP0005319_abnormal_enzyme/_coenzyme | 0.63383152 |
| 180 | MP0000477_abnormal_intestine_morphology | 0.62761057 |
| 181 | MP0002638_abnormal_pupillary_reflex | 0.62009440 |
| 182 | MP0002136_abnormal_kidney_physiology | 0.61658387 |
| 183 | MP0000747_muscle_weakness | 0.60793163 |
| 184 | MP0002998_abnormal_bone_remodeling | 0.60639432 |
| 185 | MP0001881_abnormal_mammary_gland | 0.59597833 |
| 186 | MP0005551_abnormal_eye_electrophysiolog | 0.59240740 |
| 187 | MP0009643_abnormal_urine_homeostasis | 0.59217666 |
| 188 | MP0010386_abnormal_urinary_bladder | 0.58730495 |
| 189 | MP0001986_abnormal_taste_sensitivity | 0.58399295 |
| 190 | MP0003956_abnormal_body_size | 0.57750267 |
| 191 | MP0003938_abnormal_ear_development | 0.55833449 |
| 192 | MP0003137_abnormal_impulse_conducting | 0.55053839 |
| 193 | MP0000026_abnormal_inner_ear | 0.50377311 |
| 194 | MP0000537_abnormal_urethra_morphology | 0.49499650 |
| 195 | MP0003942_abnormal_urinary_system | 0.47921360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.73495863 |
| 2 | Focal motor seizures (HP:0011153) | 5.48126963 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.21180731 |
| 4 | Focal seizures (HP:0007359) | 4.85969754 |
| 5 | Chronic otitis media (HP:0000389) | 4.74601484 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.61718181 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.56095897 |
| 8 | Nasal polyposis (HP:0100582) | 4.47005743 |
| 9 | T lymphocytopenia (HP:0005403) | 4.44680406 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.41077017 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 4.34843088 |
| 12 | Atonic seizures (HP:0010819) | 4.32219651 |
| 13 | Abnormality of T cell number (HP:0011839) | 4.31508793 |
| 14 | Febrile seizures (HP:0002373) | 4.22438621 |
| 15 | Recurrent bronchitis (HP:0002837) | 4.17620342 |
| 16 | Ankle clonus (HP:0011448) | 4.03093163 |
| 17 | Stomatitis (HP:0010280) | 3.97219036 |
| 18 | Action tremor (HP:0002345) | 3.96653760 |
| 19 | Abnormality of T cells (HP:0002843) | 3.89922522 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.86036889 |
| 21 | Recurrent viral infections (HP:0004429) | 3.85265647 |
| 22 | IgM deficiency (HP:0002850) | 3.81097875 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.81065363 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.80818438 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.80818438 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.74941287 |
| 27 | Severe combined immunodeficiency (HP:0004430) | 3.74514023 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72214698 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.65130106 |
| 30 | Thrombocytosis (HP:0001894) | 3.56459796 |
| 31 | Pustule (HP:0200039) | 3.54817515 |
| 32 | * Spastic gait (HP:0002064) | 3.46982572 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.42629917 |
| 34 | Generalized tonic-clonic seizures (HP:0002069) | 3.41178314 |
| 35 | Myositis (HP:0100614) | 3.41092141 |
| 36 | Limb dystonia (HP:0002451) | 3.41018219 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.30190445 |
| 38 | Neurofibrillary tangles (HP:0002185) | 3.27622143 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23368512 |
| 40 | Cerebral hypomyelination (HP:0006808) | 3.20324501 |
| 41 | Recurrent skin infections (HP:0001581) | 3.19632026 |
| 42 | Inflammation of the large intestine (HP:0002037) | 3.17820500 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 3.14163302 |
| 44 | Meningitis (HP:0001287) | 3.12420795 |
| 45 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.06759183 |
| 46 | Abnormality of binocular vision (HP:0011514) | 3.04578137 |
| 47 | Diplopia (HP:0000651) | 3.04578137 |
| 48 | Epileptiform EEG discharges (HP:0011182) | 3.03677723 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 3.02931667 |
| 50 | Increased IgE level (HP:0003212) | 3.02474575 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 3.02124533 |
| 52 | Absence seizures (HP:0002121) | 3.00881852 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.96473285 |
| 54 | Lymphopenia (HP:0001888) | 2.96242647 |
| 55 | Truncal ataxia (HP:0002078) | 2.93629719 |
| 56 | Abnormal eating behavior (HP:0100738) | 2.93476875 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.92164711 |
| 58 | * Urinary urgency (HP:0000012) | 2.91994188 |
| 59 | Obstructive lung disease (HP:0006536) | 2.91124401 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91124401 |
| 61 | Gastrointestinal infarctions (HP:0005244) | 2.90971641 |
| 62 | Mutism (HP:0002300) | 2.88691957 |
| 63 | Insomnia (HP:0100785) | 2.87705480 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.87326404 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.87037094 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.86970787 |
| 67 | Progressive cerebellar ataxia (HP:0002073) | 2.86942438 |
| 68 | Vasculitis (HP:0002633) | 2.84662304 |
| 69 | IgG deficiency (HP:0004315) | 2.83392048 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.81488045 |
| 71 | Epistaxis (HP:0000421) | 2.77841383 |
| 72 | Akinesia (HP:0002304) | 2.75402426 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.75227335 |
| 74 | Depression (HP:0000716) | 2.74350855 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.74230368 |
| 76 | B lymphocytopenia (HP:0010976) | 2.74230368 |
| 77 | Torticollis (HP:0000473) | 2.73894297 |
| 78 | Gingival bleeding (HP:0000225) | 2.72347985 |
| 79 | Chest pain (HP:0100749) | 2.71993874 |
| 80 | Colitis (HP:0002583) | 2.69609164 |
| 81 | Drooling (HP:0002307) | 2.69266524 |
| 82 | Dialeptic seizures (HP:0011146) | 2.69169461 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.68669307 |
| 84 | Periodontitis (HP:0000704) | 2.68314764 |
| 85 | Eosinophilia (HP:0001880) | 2.67292315 |
| 86 | Failure to thrive in infancy (HP:0001531) | 2.66859496 |
| 87 | Joint swelling (HP:0001386) | 2.66140726 |
| 88 | Chronic diarrhea (HP:0002028) | 2.65681595 |
| 89 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.65228283 |
| 90 | Leukocytosis (HP:0001974) | 2.64534774 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 2.63390655 |
| 92 | Tetraplegia (HP:0002445) | 2.63044609 |
| 93 | Papilloma (HP:0012740) | 2.60616259 |
| 94 | Verrucae (HP:0200043) | 2.60616259 |
| 95 | Amblyopia (HP:0000646) | 2.57625649 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 2.56213784 |
| 97 | Annular pancreas (HP:0001734) | 2.55844130 |
| 98 | Visual hallucinations (HP:0002367) | 2.52600974 |
| 99 | Granulocytopenia (HP:0001913) | 2.51855643 |
| 100 | Gingivitis (HP:0000230) | 2.50798727 |
| 101 | Hemoptysis (HP:0002105) | 2.50385734 |
| 102 | Lower limb muscle weakness (HP:0007340) | 2.49718301 |
| 103 | Impaired platelet aggregation (HP:0003540) | 2.47691792 |
| 104 | Abnormal platelet function (HP:0011869) | 2.47691792 |
| 105 | Polyphagia (HP:0002591) | 2.47170377 |
| 106 | Thyroiditis (HP:0100646) | 2.46662760 |
| 107 | Neuronal loss in central nervous system (HP:0002529) | 2.45092884 |
| 108 | Abnormality of the fingertips (HP:0001211) | 2.45065260 |
| 109 | Postural instability (HP:0002172) | 2.44981673 |
| 110 | Poor eye contact (HP:0000817) | 2.44203581 |
| 111 | Pulmonary infiltrates (HP:0002113) | 2.44089464 |
| 112 | * Dysmetria (HP:0001310) | 2.43140675 |
| 113 | Recurrent sinusitis (HP:0011108) | 2.42757635 |
| 114 | Peripheral hypomyelination (HP:0007182) | 2.42733273 |
| 115 | Excessive salivation (HP:0003781) | 2.42697029 |
| 116 | Apathy (HP:0000741) | 2.41322360 |
| 117 | Intention tremor (HP:0002080) | 2.41223094 |
| 118 | Encephalitis (HP:0002383) | 2.40325658 |
| 119 | Obstructive sleep apnea (HP:0002870) | 2.40087275 |
| 120 | Interstitial pulmonary disease (HP:0006530) | 2.39114975 |
| 121 | Chronic sinusitis (HP:0011109) | 2.39088508 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 2.37588686 |
| 123 | Delusions (HP:0000746) | 2.37577531 |
| 124 | Status epilepticus (HP:0002133) | 2.36694883 |
| 125 | Cellulitis (HP:0100658) | 2.35849838 |
| 126 | Sleep apnea (HP:0010535) | 2.34624750 |
| 127 | Lower limb amyotrophy (HP:0007210) | 2.34153945 |
| 128 | Hypoplasia of the thymus (HP:0000778) | 2.33207887 |
| 129 | Absent speech (HP:0001344) | 2.32272430 |
| 130 | Increased IgM level (HP:0003496) | 2.31939234 |
| 131 | Arterial thrombosis (HP:0004420) | 2.31135707 |
| 132 | Abnormal platelet volume (HP:0011876) | 2.30629487 |
| 133 | Prolonged bleeding time (HP:0003010) | 2.29957788 |
| 134 | Bronchitis (HP:0012387) | 2.29245006 |
| 135 | Focal dystonia (HP:0004373) | 2.28136926 |
| 136 | Pulmonary embolism (HP:0002204) | 2.28135036 |
| 137 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.26633440 |
| 138 | Clonus (HP:0002169) | 2.26562617 |
| 139 | Petechiae (HP:0000967) | 2.24362709 |
| 140 | Abnormality of macrophages (HP:0004311) | 2.22547928 |
| 141 | Anxiety (HP:0000739) | 2.21526207 |
| 142 | CNS hypomyelination (HP:0003429) | 2.20600741 |
| 143 | Cortical dysplasia (HP:0002539) | 2.20437275 |
| 144 | Hand muscle atrophy (HP:0009130) | 2.19402255 |
| 145 | Termporal pattern (HP:0011008) | 2.16946741 |
| 146 | Insidious onset (HP:0003587) | 2.16946741 |
| 147 | Diminished motivation (HP:0000745) | 2.16646370 |
| 148 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.14857528 |
| 149 | Hyperacusis (HP:0010780) | 2.13629256 |
| 150 | Upper limb amyotrophy (HP:0009129) | 2.10990677 |
| 151 | Distal upper limb amyotrophy (HP:0007149) | 2.10990677 |
| 152 | Deep venous thrombosis (HP:0002625) | 2.09884293 |
| 153 | Hypoplasia of the brainstem (HP:0002365) | 2.09805920 |
| 154 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.09805920 |
| 155 | Orchitis (HP:0100796) | 2.08585508 |
| 156 | Fatigue (HP:0012378) | 2.08494722 |
| 157 | Cheilitis (HP:0100825) | 2.06853202 |
| 158 | Bradykinesia (HP:0002067) | 2.06811038 |
| 159 | Hemiparesis (HP:0001269) | 2.06631685 |
| 160 | Broad-based gait (HP:0002136) | 2.05724120 |
| 161 | Craniofacial dystonia (HP:0012179) | 2.05652199 |
| 162 | Abnormal social behavior (HP:0012433) | 2.04574853 |
| 163 | Impaired social interactions (HP:0000735) | 2.04574853 |
| 164 | Hypoplasia of the corpus callosum (HP:0002079) | 2.04303512 |
| 165 | Pointed chin (HP:0000307) | 2.03623993 |
| 166 | Hepatitis (HP:0012115) | 2.03372841 |
| 167 | Hammertoe (HP:0001765) | 2.03346980 |
| 168 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01799936 |
| 169 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01799936 |
| 170 | Urticaria (HP:0001025) | 2.01528448 |
| 171 | Scanning speech (HP:0002168) | 2.01434394 |
| 172 | Skin ulcer (HP:0200042) | 2.01305832 |
| 173 | IgA deficiency (HP:0002720) | 2.01290399 |
| 174 | Impaired smooth pursuit (HP:0007772) | 2.01219607 |
| 175 | Spastic tetraparesis (HP:0001285) | 2.01138821 |
| 176 | Joint hemorrhage (HP:0005261) | 1.99788975 |
| 177 | Retinal dysplasia (HP:0007973) | 1.98466279 |
| 178 | Abnormality of the prostate (HP:0008775) | 1.97482079 |
| 179 | Increased density of long bones (HP:0006392) | 1.97336174 |
| 180 | Spastic tetraplegia (HP:0002510) | 1.96656672 |
| 181 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96161682 |
| 182 | Hypoventilation (HP:0002791) | 1.95610673 |
| 183 | Emphysema (HP:0002097) | 1.94067557 |
| 184 | Incomplete penetrance (HP:0003829) | 1.90943903 |
| 185 | Gastrointestinal stroma tumor (HP:0100723) | 1.90513529 |
| 186 | Myocardial infarction (HP:0001658) | 1.89905109 |
| 187 | Lymphoma (HP:0002665) | 1.87731237 |
| 188 | Hypobetalipoproteinemia (HP:0003563) | 1.87722265 |
| 189 | Increased mean platelet volume (HP:0011877) | 1.87449602 |
| 190 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85957726 |
| 191 | Skin rash (HP:0000988) | 1.85531065 |
| 192 | Thoracic kyphosis (HP:0002942) | 1.85385437 |
| 193 | Paraplegia (HP:0010550) | 1.83392190 |
| 194 | Hyperventilation (HP:0002883) | 1.82942275 |
| 195 | Genetic anticipation (HP:0003743) | 1.82601356 |
| 196 | Rapidly progressive (HP:0003678) | 1.82166068 |
| 197 | Split foot (HP:0001839) | 1.81481790 |
| 198 | Poor suck (HP:0002033) | 1.78279860 |
| 199 | Papilledema (HP:0001085) | 1.78236546 |
| 200 | Spastic paraplegia (HP:0001258) | 1.76115043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.72519209 |
| 2 | MARK1 | 5.04201023 |
| 3 | EPHA4 | 4.01034903 |
| 4 | PAK6 | 3.50999634 |
| 5 | TXK | 3.36056470 |
| 6 | ZAP70 | 3.05548112 |
| 7 | NTRK3 | 3.00064025 |
| 8 | GRK6 | 2.71077159 |
| 9 | TYK2 | 2.62240635 |
| 10 | JAK3 | 2.59975580 |
| 11 | NTRK2 | 2.56325085 |
| 12 | PRKD3 | 2.47195958 |
| 13 | NTRK1 | 2.39098591 |
| 14 | ITK | 2.36627516 |
| 15 | CASK | 2.36052570 |
| 16 | FGFR4 | 2.32289159 |
| 17 | BLK | 2.26224009 |
| 18 | MINK1 | 2.25705082 |
| 19 | ERN1 | 2.23273354 |
| 20 | UHMK1 | 2.21581913 |
| 21 | EEF2K | 2.21011843 |
| 22 | MAP2K7 | 2.16082196 |
| 23 | IKBKE | 2.13747657 |
| 24 | STK10 | 2.09949667 |
| 25 | TRIB3 | 2.01688630 |
| 26 | JAK1 | 1.99948977 |
| 27 | MAP3K14 | 1.97759423 |
| 28 | PKN2 | 1.95671987 |
| 29 | TBK1 | 1.92160080 |
| 30 | MAP3K4 | 1.89447434 |
| 31 | MAP3K13 | 1.88814669 |
| 32 | MAPK13 | 1.85716962 |
| 33 | BTK | 1.83865811 |
| 34 | TESK2 | 1.82898499 |
| 35 | MAP3K10 | 1.69805530 |
| 36 | IRAK4 | 1.69079075 |
| 37 | SYK | 1.68573641 |
| 38 | TEC | 1.62716776 |
| 39 | FES | 1.61348367 |
| 40 | LATS2 | 1.59103657 |
| 41 | ARAF | 1.52819765 |
| 42 | LCK | 1.52051386 |
| 43 | PHKG2 | 1.48701797 |
| 44 | PHKG1 | 1.48701797 |
| 45 | LRRK2 | 1.48695988 |
| 46 | TAOK1 | 1.48014532 |
| 47 | CSK | 1.45666821 |
| 48 | SIK2 | 1.45452302 |
| 49 | LIMK1 | 1.44952959 |
| 50 | KDR | 1.43615602 |
| 51 | KIT | 1.41506558 |
| 52 | CAMK2B | 1.40487386 |
| 53 | HCK | 1.40430144 |
| 54 | CDK5 | 1.39587992 |
| 55 | CDK18 | 1.36360056 |
| 56 | CDK15 | 1.36201296 |
| 57 | CDK14 | 1.29499866 |
| 58 | MAP2K3 | 1.27818996 |
| 59 | CDK11A | 1.26181778 |
| 60 | PLK2 | 1.24149403 |
| 61 | RIPK4 | 1.22287630 |
| 62 | BRSK1 | 1.17701129 |
| 63 | MAP3K12 | 1.16760799 |
| 64 | TAOK3 | 1.15054464 |
| 65 | FGFR3 | 1.12661561 |
| 66 | PRKCG | 1.12098779 |
| 67 | ICK | 1.10906888 |
| 68 | EPHB1 | 1.10479322 |
| 69 | IKBKB | 1.10478974 |
| 70 | TYRO3 | 1.09807497 |
| 71 | MAP3K11 | 1.07802108 |
| 72 | JAK2 | 1.06689887 |
| 73 | STK38 | 1.06604189 |
| 74 | CSF1R | 1.04892236 |
| 75 | BCR | 1.04150797 |
| 76 | MAP2K4 | 0.99014199 |
| 77 | KSR1 | 0.98860405 |
| 78 | CAMK2G | 0.98701844 |
| 79 | PRKCQ | 0.96333960 |
| 80 | NLK | 0.94349552 |
| 81 | CAMKK2 | 0.93783360 |
| 82 | CSNK1G2 | 0.93679601 |
| 83 | RPS6KA4 | 0.93159053 |
| 84 | PRKCH | 0.92606756 |
| 85 | CAMK1 | 0.89507906 |
| 86 | DYRK1A | 0.88917910 |
| 87 | MAP3K7 | 0.87489461 |
| 88 | TESK1 | 0.87233715 |
| 89 | DYRK2 | 0.85912383 |
| 90 | LYN | 0.85895633 |
| 91 | PTK6 | 0.85184001 |
| 92 | CSNK1A1L | 0.84738549 |
| 93 | GRK5 | 0.84684755 |
| 94 | SIK1 | 0.84629806 |
| 95 | CAMK2A | 0.83815987 |
| 96 | PAK3 | 0.83396892 |
| 97 | TNK2 | 0.82871668 |
| 98 | LMTK2 | 0.81676940 |
| 99 | SGK223 | 0.81352682 |
| 100 | SGK494 | 0.81352682 |
| 101 | CSNK1G3 | 0.79556088 |
| 102 | CHUK | 0.77735841 |
| 103 | MST4 | 0.74752553 |
| 104 | PIM1 | 0.74429483 |
| 105 | NME2 | 0.73500677 |
| 106 | SIK3 | 0.71663697 |
| 107 | PIM2 | 0.71523245 |
| 108 | CAMK4 | 0.71412222 |
| 109 | DAPK1 | 0.70533100 |
| 110 | CLK1 | 0.70482092 |
| 111 | ALK | 0.70068864 |
| 112 | RAF1 | 0.70020037 |
| 113 | SCYL2 | 0.69609247 |
| 114 | BRAF | 0.68439293 |
| 115 | PKN1 | 0.67736400 |
| 116 | PDK1 | 0.66934293 |
| 117 | FLT3 | 0.64202411 |
| 118 | MAP2K6 | 0.63231698 |
| 119 | PRKCI | 0.62329509 |
| 120 | MAPK10 | 0.62321609 |
| 121 | PTK2 | 0.59228197 |
| 122 | PINK1 | 0.59119392 |
| 123 | CAMK2D | 0.58861801 |
| 124 | MAP3K6 | 0.57203897 |
| 125 | TRIM28 | 0.56601444 |
| 126 | PDGFRA | 0.55183492 |
| 127 | PRPF4B | 0.54650726 |
| 128 | MAP3K8 | 0.53018458 |
| 129 | DAPK3 | 0.52906274 |
| 130 | MAPK12 | 0.52015274 |
| 131 | PRKCZ | 0.51107261 |
| 132 | MARK3 | 0.51070229 |
| 133 | MAPK4 | 0.50028768 |
| 134 | RPS6KA2 | 0.49225615 |
| 135 | MAP3K1 | 0.48583994 |
| 136 | IRAK3 | 0.48295377 |
| 137 | MAPK11 | 0.46982519 |
| 138 | CDK4 | 0.46478395 |
| 139 | RPS6KA3 | 0.45732191 |
| 140 | FYN | 0.41584461 |
| 141 | NEK6 | 0.41519921 |
| 142 | CCNB1 | 0.40144290 |
| 143 | CDK12 | 0.39363320 |
| 144 | MAPKAPK5 | 0.39138943 |
| 145 | SGK3 | 0.38493176 |
| 146 | KSR2 | 0.38348782 |
| 147 | PNCK | 0.37775184 |
| 148 | CSNK1G1 | 0.37747085 |
| 149 | CSNK1D | 0.36747935 |
| 150 | TGFBR2 | 0.36361488 |
| 151 | CAMKK1 | 0.36213383 |
| 152 | CSNK1E | 0.34136721 |
| 153 | SGK1 | 0.33329915 |
| 154 | ROCK2 | 0.33284800 |
| 155 | RET | 0.32261497 |
| 156 | DAPK2 | 0.31597993 |
| 157 | RPS6KB1 | 0.31388312 |
| 158 | CDK19 | 0.31233972 |
| 159 | RPS6KA6 | 0.31016906 |
| 160 | TAOK2 | 0.30808721 |
| 161 | MAPK8 | 0.29817401 |
| 162 | GSK3B | 0.29636112 |
| 163 | AURKA | 0.29379325 |
| 164 | HIPK2 | 0.27133051 |
| 165 | ABL1 | 0.26377333 |
| 166 | MARK2 | 0.26179037 |
| 167 | EGFR | 0.26091366 |
| 168 | PDPK1 | 0.24735407 |
| 169 | MAP3K9 | 0.24709596 |
| 170 | MAP3K5 | 0.23325463 |
| 171 | PRKCD | 0.23293158 |
| 172 | STK11 | 0.23115453 |
| 173 | TTN | 0.22927728 |
| 174 | EIF2AK3 | 0.21605208 |
| 175 | PDGFRB | 0.21443511 |
| 176 | RPS6KL1 | 0.19829351 |
| 177 | RPS6KC1 | 0.19829351 |
| 178 | CDK6 | 0.19803919 |
| 179 | RIPK1 | 0.19751856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.97201166 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.25550731 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.12187566 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.14882514 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.05768641 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.83226030 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66003127 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.59093354 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.58585365 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51884421 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.47569948 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.40819090 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.40155114 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38005226 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.36499770 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36232329 |
| 17 | Measles_Homo sapiens_hsa05162 | 2.35287760 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34089462 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.33549302 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30258118 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18229186 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.15479873 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11562133 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 2.01143947 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.86827823 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83393758 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76214298 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74802319 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74124513 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73641955 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68263766 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68029084 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67554544 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59980115 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59919112 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58159310 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58154489 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.56032368 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53854504 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51068071 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48495680 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.45237543 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.42986447 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42843900 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42482876 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.41469024 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39379183 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39070566 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34331137 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33839404 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32448469 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.31938186 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31712145 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 1.30197239 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 1.29215063 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28630022 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 1.27654380 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 1.25825795 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.22400568 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 1.21289296 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20053761 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 1.19621695 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.19612808 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17762913 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17559132 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15868604 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14911396 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 1.14211100 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13578992 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12156171 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11562917 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11391599 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09671971 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 1.08977697 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.08664952 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08384587 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 1.07845324 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07770422 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06653091 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06192521 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06123083 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05187410 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03688182 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00778478 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.93847587 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92863863 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91721150 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91479709 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91200897 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.89345787 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.89202027 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88668397 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87743638 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.87467344 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84997934 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.83916494 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83414826 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.83287056 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83229403 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82611430 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82260884 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81680257 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81193933 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80396817 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78943852 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77982614 |
| 107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76542496 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76531363 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.75463327 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73372911 |
| 111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73161581 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71519004 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70590418 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68911889 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.65119144 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64840855 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64420791 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62530776 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62265222 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62210038 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60918522 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.60821927 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59318829 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58861835 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57791862 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57464665 |
| 127 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57128997 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56351154 |
| 129 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56237673 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53972599 |
| 131 | Phototransduction_Homo sapiens_hsa04744 | 0.53876519 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.53344544 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52931228 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52864771 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51980370 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51934324 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51445763 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50835535 |
| 139 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50677813 |
| 140 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50421089 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.50411612 |
| 142 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50220779 |
| 143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49841916 |
| 144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49592473 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47472156 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47349910 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44546201 |
| 148 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43618510 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43232378 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41566140 |
| 151 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41064688 |
| 152 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41063460 |
| 153 | Bile secretion_Homo sapiens_hsa04976 | 0.40849993 |
| 154 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40711656 |
| 155 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39206713 |
| 156 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38913268 |
| 157 | Endocytosis_Homo sapiens_hsa04144 | 0.38488426 |
| 158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38456999 |
| 159 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38097835 |
| 160 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37403620 |
| 161 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36978088 |
| 162 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36638415 |
| 163 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35967155 |
| 164 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35746658 |
| 165 | Tight junction_Homo sapiens_hsa04530 | 0.34872085 |
| 166 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34350565 |
| 167 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34154009 |
| 168 | Lysosome_Homo sapiens_hsa04142 | 0.33919647 |
| 169 | Lysine degradation_Homo sapiens_hsa00310 | 0.33665467 |
| 170 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33185186 |
| 171 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33109215 |
| 172 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32926813 |
| 173 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32473106 |
| 174 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31504007 |
| 175 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31394853 |
| 176 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30468472 |
| 177 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30233516 |
| 178 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.28597667 |
| 179 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25667791 |
| 180 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25224327 |
| 181 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25221374 |
| 182 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24439978 |
| 183 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23294535 |
| 184 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22730070 |

